Ушбу иш иқтибос қилган ишлар

106 та иш

Иш: Theranostics in nuclear medicine practice

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

   Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit +6

   Мақола20147 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011675

2. The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy.

   Jean L. Richardson, Gary Marks, A Levine

   Мақола19883 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011677

3. Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

   Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin +32

   Мақола20173 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011754

4. Production logistics of 177Lu for radionuclide therapy

   M.R.A. Pillai, Sudipta Chakraborty, Tapas Das +2

   Мақола20032 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011688

5. LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN

   E. P. Krenning, Wout A. P. Breeman, P.P.M. Kooij +6

   Мақола19892 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011698

6. 123I-<i>Meta</i>-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis

   Arnold Jacobson, Hsiaowei Deng, John Lombard +2

   Шарҳ мақола20102 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011699

7. Treatment With the Radiolabeled Somatostatin Analog [ ¹⁷⁷ Lu-DOTA ⁰ ,Tyr ³ ]Octreotate: Toxicity, Efficacy, and Survival

   Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam +6

   Мақола20082 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011723

8. Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

   Guru Sonpavde, Phillip Periman, D. M. Bernold +8

   Мақола20092 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011725

9. A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β⁻-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative

   Cristina Müller, Konstantin Zhernosekov, U. Köster +6

   Мақола20122 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.011733

10. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

    M. Stimpfel, Irma Virant‐Klun

    Мақола20162 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011743

11. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011667

12. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011668

13. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011669

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011670

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011671

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011672

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011673

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011674

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011676

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011678

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011679

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011680

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011681

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011682

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.011683